A-V IMPULSE SYSTEM

Welcome to the Brand page for “A-V IMPULSE SYSTEM”, which is offered here for Medical apparatus, an ex-vivo anatomical pump, impulse generator and controls therefor, sold as a unit, used for the reduction of post-operative and post-traumatic pain and swelling; for the reduction of compartmental pressures to avoid fasciotomy and associated complications; for pre-operative and post-operative prohylaxis of deep vein thrombosis; for the treatment of sudeck's syndrome (reflex sympathetic dystrophy); for maintaining patency and reducing edema in high-risk limb bypass grafts; i.e., femorodistal tibial graft; for a reduction in rest pain and maintenance of circulation in patients awaiting surgery; for the stimulation of circulation in peripheral vascular disease in the critically ischemic limb to maintain limb viability; for the treatment of exacerbations of raynaud's disease; for the stimulation of circulation in patients at risk of developing ischemic ulceration (diabetes, etc.); for the enhancement of blood supply prior to grafting; and for the treatment of venous ulceration and in the avoidance of recurrence;.

Its status is currently believed to be active. Its class is unavailable. “A-V IMPULSE SYSTEM” is believed to be currently owned by “CARDINAL HEALTH IRELAND UNLIMITED COMPANY”.

Owner:
CARDINAL HEALTH IRELAND UNLIMITED COMPANY
Owner Details
Description:
Medical apparatus, an ex-vivo anatomical pump, impulse generator and controls therefor, sold as a unit, used for the reduction of post-operative and post-traumatic pain and swelling; for the reduction of compartmental pressures to avoid fasciotomy and associated complications; for pre-operative and post-operative prohylaxis of deep vein thrombosis; for the treatment of Sudeck's syndrome (reflex sympathetic dystrophy); for maintaining patency and reducing edema in high-risk limb bypass grafts; i.e., femorodistal tibial graft; for a reduction in rest pain and maintenance of circulation in patients awaiting surgery; for the stimulation of circulation in peripheral vascular disease in the critically ischemic limb to maintain limb viability; for the treatment of exacerbations of Raynaud's Disease; for the stimulation of circulation in patients at risk of developing ischemic ulceration (Diabetes, etc.); for the enhancement of blood supply prior to grafting; and for the treatment of venous ulceration and in the avoidance of recurrence;
Categories: MEDICAL APPARATUS